Control 1: Any person using these vaccines must ensure that these vaccines are only administered to equine animals such as horses, donkeys, and zebras, and only by a veterinarian who has been trained, specifically on the controls placed on the use of this vaccine by MPI.
Control 2: Any registrant of the vaccine must maintain records of vaccine stocks and must make those records available to MPI for auditing.
Control 3: Any MPI-approved person storing these vaccines must ensure that the vaccines are stored in a secure location and ensure that the expired vaccines are disposed of as hazardous waste. Also, that person must ensure that a record is kept of all the vaccine stock coming into and going out of such a location and must make those records available to MPI for audit.
Control 4: Any person storing, transporting or using these vaccines must ensure that any spills including storage facility and one-off spills of the vaccine are disinfected by treating with the best available and most appropriate disinfectant (eg, 70% ethanol). In addition, any spills should be recorded and notified to MPI and to the EPA.
Control 5: Any person using these vaccines must ensure that contaminated waste from the genetically modified vaccines (including syringes, needles, disposable overalls, gloves, masks and any other material exposed to the genetically modified product) must be collected, treated and disposed of as hazardous waste. Disposal of expired vaccines must be in accord with the requirements of MAF/ERMA New Zealand Standard Facilities for Microorganisms and Cell Cultures: 2007a.
Control 6: The vaccines can only be used on equine animals for export to a country that requires vaccination for Equine influenza, or in an Equine Influenza outbreak in New Zealand as defined by MPI.